Association between quality of life and clinical outcome in women with advanced epithelial ovarian cancer receiving chemotherapy with concurrent and maintenance bevacizumab: Results from a prospective multicenter phase III NRG Oncology/Gynecologic Oncology Group (GOG) trial

Journal article

Peer reviewed

N.T. Phippen, B.A. Davidson, S. Wolf, G. Samsa, D. Cella, L.J. Havrilesky, R.A. Burger, A.A. Secord, B.J. Monk and C.A. Leath

Gynecologic oncology, Vol.138, pp.2-2

05/01/2015

Metrics

1 Record Views

Title: Association between quality of life and clinical outcome in women with advanced epithelial ovarian cancer receiving chemotherapy with concurrent and maintenance bevacizumab: Results from a prospective multicenter phase III NRG Oncology/Gynecologic Oncology Group (GOG) trial
Creators: N.T. Phippen - Walter Reed National Military Medical Center
B.A. Davidson - Duke University Medical Center, Durham, NC, USA
S. Wolf - Duke Medical Center
G. Samsa - Duke Medical Center
D. Cella - Northwestern University
L.J. Havrilesky - Duke Medical Center
R.A. Burger - University of Pennsylvania
A.A. Secord - Duke Medical Center
B.J. Monk - University of Arizona
C.A. Leath - University of Alabama at Birmingham
Publication Details: Gynecologic oncology, Vol.138, pp.2-2
Publisher: Elsevier Inc
Identifiers: 991005968878702656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article